FDA Bans Import of Meds From Major Drug Maker

In a major drug safety alert, the Food and Drug Administration announced today that the U.S. can refuse to import dozens of generic drugs taken by millions of Americans that are made by a major drug manufacturer in India. People taking any of 30 generic medications, such as the generics of Cipro, Alavert and Claritin, all made at two Ranbaxy plants in India, could be affected by today's alert. But the FDA said that drug shortages are not expected in the United States, because, in all instances...Full Story
Commenting on this article is closed.